Pharmacological inhibition of Eph receptors enhances glucose-stimulated insulin 
secretion from mouse and human pancreatic islets.

Jain, Ruchi; Jain, D; Liu, Q; Bartosinska, B; Wang, J; Schumann, D; Kauschke, S G; Eickelmann, Peter; Piemonti, Lorenzo; Gray, N S; Lammert, Eckhard

Datensatz

DATENSATZ AKTIONENEXPORT

Zur Ablage hinzufügen

Lokale TagsStatistikFreigabegeschichteDetailsÜbersicht

Freigegeben

Zeitschriftenartikel

Pharmacological inhibition of Eph receptors enhances glucose-stimulated insulin secretion from mouse and human pancreatic islets.

MPG-Autoren

/persons/resource/persons219265

Jain, Ruchi
Max Planck Institute of Molecular Cell Biology and Genetics, Max Planck Society;

/persons/resource/persons219367

Lammert, Eckhard
Max Planck Institute of Molecular Cell Biology and Genetics, Max Planck Society;

Externe Ressourcen

Es sind keine Externen Ressourcen verfügbar

Volltexte (frei zugänglich)

Es sind keine frei zugänglichen Volltexte verfügbar

Ergänzendes Material (frei zugänglich)

Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar

Zitation

Jain, R., Jain, D., Liu, Q., Bartosinska, B., Wang, J., Schumann, D., et al. (2013). Pharmacological inhibition of Eph receptors enhances glucose-stimulated insulin secretion from mouse and human pancreatic islets. Diabetologia, 56(6), 1350-1355.

Zitierlink: http://hdl.handle.net/21.11116/0000-0001-0720-3

Zusammenfassung

Type 2 diabetes is characterised by impaired glucose-stimulated insulin secretion (GSIS) from pancreatic islets. Since erythropoietin-producing hepatoma (Eph)-ephrin bidirectional signalling fine-tunes GSIS from pancreatic beta cells, we investigated Eph receptor tyrosine kinases (RTK) as potential drug targets for selectively increasing GSIS.